Almac Group Moves to Number Five in Ulster Business Top 100 Companies List

2018/19 figures report turnover increased by £85M with 7% growth in global workforce

Craigavon, N.I., 20 Aug 2020 – Craigavon based Almac Group, the global contract pharmaceutical development and manufacturing organisation, is honoured to move up three positions to number five in this year’s Ulster Business “Most valuable businesses” table.

For the third consecutive year, the Group was also listed in a supplementary report detailing the “Most profitable companies in Northern Ireland”, and moved up from tenth place in 2019 to this year’s number eight.

Niall Harkin, Almac Group Finance Director, commented: “We are delighted to see Almac placed at number five in this year’s Ulster Business Top 100 companies tables. 2019 was a highly successful year for Almac as we continued to invest significantly in our people, facilities and unique solutions to ensure our growing client base are offered the most flexible, innovative and efficient services in our marketplace with the sole aim of advancing the health of patients across the world.  Achieving recognition in these listings, and indeed our overall success, is testament to the dedication, expertise and contribution of our ever increasing global and diverse employee base.”

The news comes as the Group’s figures for year ending 30 September 2019 reported a £85.4 million rise in turnover at £634.3 million with pre-tax profits recorded at £47.6 million, up from £27.6 million, while average global employee figures increased from 4,798 to 5,150 during the same period. Since these figures were published, much has changed in the pharmaceutical industry as a result of the impact of the current pandemic, however Almac continues to conduct its critical business operations across all its locations and is currently supporting over 80 separate crucial research programs to accelerate COVID-19 treatment.

The Ulster Business Top 100 list has showcased the performance of the biggest firms from right across Northern Ireland, ranked by turnover, for more than 30 years. The annual report is sponsored by A&L Goodbody and uses a combination of data sourced from both Dun & Bradstreet’s information database and Companies House.  It incorporates the results of Northern Ireland based companies, either Northern Ireland registered, or when a significant portion of their business is driven and transacted through the province.

ENDS

About Almac Group

A unique culture delivering exceptional solutions

The Almac Group is an established contract development and manufacturing organisation providing an extensive range of integrated services across the drug development lifecycle to the pharmaceutical and biotech sectors globally. Its innovative services range from R&D, biomarker discovery development and commercialisation, API manufacture, analytical services, formulation development, clinical trial supply, IRT (IVRS/IWRS) through to commercial-scale manufacture.

The international company is a privately owned organisation which has grown organically over the past five decades now employing over 5,600 highly skilled personnel across 18 facilities including Europe, the US and Asia.

To keep up to date with latest news, follow us on Twitter and LinkedIn or visit almacgroup.com.